Ethyl vanillin isobutyrate
Common Name: |
Ethyl vanillin isobutyrate |
IUPAC Name: |
(2-ethoxy-4-formylphenyl) 2-methylpropanoate |
Molecular Formula: |
C9H10O3 |
SMILES: |
CCOC1=C(C=CC(=C1)C=O)OC(=O)C(C)C |
Inchi: |
1S/C13H16O4/c1-4-16-12-7-10(8-14)5-6-11(12)17-13(15)9(2)3/h5-9H,4H2,1-3H3 |
Inchi Key: |
BTCQMCOBMIXUCG-UHFFFAOYSA-N |
Cas No: |
188417-26-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
166.17 |
Mass (g/mol) |
236.105 |
Molar Refractivity |
44.51 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
4 |
Rings |
1 |
TPSA |
39.44 |
Hetero Atoms |
4 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
5 |
Melting Point (°C) |
57.00 |
Boiling Point (°C@760.00mm Hg) |
295.00 to 296.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.000884 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.22 |
LogP |
2.459 |
iLOGP |
2.40 |
XLOGP3 |
1.91 |
WLOGP |
1.75 |
MLOGP |
0.67 |
ESOL Log S |
-2.12 |
ESOL Solubility (mg/ml) |
1.27 |
ESOL Solubility (mol/l) |
0.008 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.36 |
Ali Solubility (mg/ml) |
0.72 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.17 |
Silicos-IT Solubility (mg/ml) |
1.11 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.96 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.049 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.008 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
1 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |